183 related articles for article (PubMed ID: 9046818)
21. Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation.
Rea D; Fourcade C; Leblond V; Rowe M; Joab I; Edelman L; Bitker MO; Gandjbakhch I; Suberbielle C; Farcet JP
Transplantation; 1994 Aug; 58(3):317-24. PubMed ID: 8053055
[TBL] [Abstract][Full Text] [Related]
22. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.
Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K
J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005
[TBL] [Abstract][Full Text] [Related]
23. In vivo dynamics of EBNA1-oriP interaction during latent and lytic replication of Epstein-Barr virus.
Daikoku T; Kudoh A; Fujita M; Sugaya Y; Isomura H; Tsurumi T
J Biol Chem; 2004 Dec; 279(52):54817-25. PubMed ID: 15498777
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr Virus BZLF1-Mediated Downregulation of Proinflammatory Factors Is Essential for Optimal Lytic Viral Replication.
Li Y; Long X; Huang L; Yang M; Yuan Y; Wang Y; Delecluse HJ; Kuang E
J Virol; 2016 Jan; 90(2):887-903. PubMed ID: 26537683
[TBL] [Abstract][Full Text] [Related]
25. The lytic origin of herpesvirus papio is highly homologous to Epstein-Barr virus ori-Lyt: evolutionary conservation of transcriptional activation and replication signals.
Ryon JJ; Fixman ED; Houchens C; Zong J; Lieberman PM; Chang YN; Hayward GS; Hayward SD
J Virol; 1993 Jul; 67(7):4006-16. PubMed ID: 8389916
[TBL] [Abstract][Full Text] [Related]
26. Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus.
Hammerschmidt W; Sugden B
Cell; 1988 Nov; 55(3):427-33. PubMed ID: 2846181
[TBL] [Abstract][Full Text] [Related]
27. Initiation of DNA replication within oriP is dispensable for stable replication of the latent Epstein-Barr virus chromosome after infection of established cell lines.
Norio P; Schildkraut CL; Yates JL
J Virol; 2000 Sep; 74(18):8563-74. PubMed ID: 10954558
[TBL] [Abstract][Full Text] [Related]
28. Reactivation of lytic replication from B cells latently infected with Epstein-Barr virus occurs with high S-phase cyclin-dependent kinase activity while inhibiting cellular DNA replication.
Kudoh A; Fujita M; Kiyono T; Kuzushima K; Sugaya Y; Izuta S; Nishiyama Y; Tsurumi T
J Virol; 2003 Jan; 77(2):851-61. PubMed ID: 12502801
[TBL] [Abstract][Full Text] [Related]
29. Multiple roles of Epstein-Barr virus SM protein in lytic replication.
Han Z; Marendy E; Wang YD; Yuan J; Sample JT; Swaminathan S
J Virol; 2007 Apr; 81(8):4058-69. PubMed ID: 17287267
[TBL] [Abstract][Full Text] [Related]
30. Replicative viral DNA in Epstein-Barr virus associated Burkitt's lymphoma biopsies.
Gutierrez MI; Bhatia K; Magrath I
Leuk Res; 1993 Mar; 17(3):285-9. PubMed ID: 8383779
[TBL] [Abstract][Full Text] [Related]
31. Complexities associated with expression of Epstein-Barr virus (EBV) lytic origins of DNA replication.
Xue SA; Griffin BE
Nucleic Acids Res; 2007; 35(10):3391-406. PubMed ID: 17478522
[TBL] [Abstract][Full Text] [Related]
32. Demethylation of the Epstein-barr virus origin of lytic replication and of the immediate early gene BZLF1 is DNA replication independent. Brief report.
Falk KI; Ernberg I
Arch Virol; 1999; 144(11):2219-27. PubMed ID: 10603176
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of S-phase cyclin-dependent kinase activity blocks expression of Epstein-Barr virus immediate-early and early genes, preventing viral lytic replication.
Kudoh A; Daikoku T; Sugaya Y; Isomura H; Fujita M; Kiyono T; Nishiyama Y; Tsurumi T
J Virol; 2004 Jan; 78(1):104-15. PubMed ID: 14671092
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus origin of lytic replication mediates association of replicating episomes with promyelocytic leukaemia protein nuclear bodies and replication compartments.
Amon W; White RE; Farrell PJ
J Gen Virol; 2006 May; 87(Pt 5):1133-1137. PubMed ID: 16603513
[TBL] [Abstract][Full Text] [Related]
35. A reporter system for Epstein-Barr virus (EBV) lytic replication: anti-EBV activity of the broad anti-herpesviral drug artesunate.
Auerochs S; Korn K; Marschall M
J Virol Methods; 2011 May; 173(2):334-9. PubMed ID: 21396962
[TBL] [Abstract][Full Text] [Related]
36. Redox control of Epstein-Barr virus replication by human thioredoxin/ATL-derived factor: differential regulation of lytic and latent infection.
Sono H; Teshigawara K; Sasada T; Takagi Y; Nishiyama A; Ohkubo Y; Maeda Y; Tatsumi E; Kanamaru A; Yodoi J
Antioxid Redox Signal; 1999; 1(2):155-65. PubMed ID: 11228744
[TBL] [Abstract][Full Text] [Related]
37. Characterization of the uracil-DNA glycosylase activity of Epstein-Barr virus BKRF3 and its role in lytic viral DNA replication.
Lu CC; Huang HT; Wang JT; Slupphaug G; Li TK; Wu MC; Chen YC; Lee CP; Chen MR
J Virol; 2007 Feb; 81(3):1195-208. PubMed ID: 17108049
[TBL] [Abstract][Full Text] [Related]
38. An Epigenetic Journey: Epstein-Barr Virus Transcribes Chromatinized and Subsequently Unchromatinized Templates during Its Lytic Cycle.
Chakravorty A; Sugden B; Johannsen EC
J Virol; 2019 Apr; 93(8):. PubMed ID: 30700606
[TBL] [Abstract][Full Text] [Related]
39. CAGE-seq analysis of Epstein-Barr virus lytic gene transcription: 3 kinetic classes from 2 mechanisms.
Djavadian R; Hayes M; Johannsen E
PLoS Pathog; 2018 Jun; 14(6):e1007114. PubMed ID: 29864140
[TBL] [Abstract][Full Text] [Related]
40. Topoisomerase I and II activities are required for Epstein-Barr virus replication.
Kawanishi M
J Gen Virol; 1993 Oct; 74 ( Pt 10)():2263-8. PubMed ID: 8409949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
